Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Umans

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
European Heart Journal|November 1, 1995
Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled studyJ P Herrman, R Simon, V A Umans, et al.
The American Journal of Cardiology|June 15, 1993
Histologic characteristics of tissue excised during directional coronary atherectomy in stable and unstable angina pectorisJ Escaned, R J van Suylen, D C MacLeod, et al.
British Heart Journal|August 1, 1991
Quantitative angiography after directional coronary atherectomyP W Serruys, V A Umans, B H Strauss, et al.
Journal of the American College of Cardiology|January 1, 1994
Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesionsD C MacLeod, B H Strauss, M de Jong, et al.
European Heart Journal|July 22, 1999
Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable anginaP Klootwijk, T Lenderink, S Meij, et al.
Coronary Artery Disease|October 1, 1993
Clinical and histological determinants of smooth-muscle cell outgrowth in cultured atherectomy specimens: importance of thrombus organizationJ Escaned, M de Jong, A G Violaris, et al.
The New England Journal of Medicine|September 21, 1995
A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica InvestigatorsP W Serruys, J P Herrman, R Simon, et al.
Journal of the American College of Cardiology|December 1, 1992
Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic resultsB H Strauss, V A Umans, R J van Suylen, et al.
International Journal of Cardiology|May 3, 2021
Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fractionM M Schreuder, A Schuurman, K M Akkerhuis, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 7, 2017
In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessmentN van Boven, K M Akkerhuis, S S Anroedh, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
European Heart Journal|November 1, 1995
Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled studyJ P Herrman, R Simon, V A Umans, et al.
The American Journal of Cardiology|June 15, 1993
Histologic characteristics of tissue excised during directional coronary atherectomy in stable and unstable angina pectorisJ Escaned, R J van Suylen, D C MacLeod, et al.
British Heart Journal|August 1, 1991
Quantitative angiography after directional coronary atherectomyP W Serruys, V A Umans, B H Strauss, et al.
Journal of the American College of Cardiology|January 1, 1994
Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesionsD C MacLeod, B H Strauss, M de Jong, et al.
European Heart Journal|July 22, 1999
Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable anginaP Klootwijk, T Lenderink, S Meij, et al.
Coronary Artery Disease|October 1, 1993
Clinical and histological determinants of smooth-muscle cell outgrowth in cultured atherectomy specimens: importance of thrombus organizationJ Escaned, M de Jong, A G Violaris, et al.
The New England Journal of Medicine|September 21, 1995
A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica InvestigatorsP W Serruys, J P Herrman, R Simon, et al.
Journal of the American College of Cardiology|December 1, 1992
Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic resultsB H Strauss, V A Umans, R J van Suylen, et al.
International Journal of Cardiology|May 3, 2021
Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fractionM M Schreuder, A Schuurman, K M Akkerhuis, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 7, 2017
In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessmentN van Boven, K M Akkerhuis, S S Anroedh, et al.
Pageof 4